XWELL, Inc. (NASDAQ: XWEL)

$1.13 -0.09 (-6.97%)
As of Apr 23, 2026 02:28 PM
Sector: Healthcare Industry: Diagnostics & Research CIK: 0001410428
Market Cap 6.51 Mn
P/E -0.23
P/S 0.22
Div. Yield -0.01
ROIC (Qtr) 0.35
Revenue Growth (1y) (Qtr) -4.19
Add ratio to table...

About

XWELL, Inc. operates as a global wellness company, focusing on providing restorative, regenerative, and reinvigorating products and services primarily to travelers. The company operates through multiple brands and has four reportable operating segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. XWELL generates revenue through its various wellness services and products, catering to travelers and other customers seeking health and wellness solutions. The company's primary products and services include spa services, COVID-19 and other medical...

Read more

Segments Breakdown of Revenue (2024)

Segments Breakdown of Revenue (2024)

Peer comparison

Companies in the Diagnostics & Research
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 TMO Thermo Fisher Scientific Inc. 197.76 Bn 29.52 4.44 39.39 Bn
2 DHR Danaher Corp /De/ 138.65 Bn 38.37 5.64 18.42 Bn
3 IDXX Idexx Laboratories Inc /De 45.76 Bn 43.17 10.63 0.45 Bn
4 A Agilent Technologies, Inc. 34.55 Bn 26.83 4.89 0.30 Bn
5 IQV Iqvia Holdings Inc. 30.20 Bn 22.18 1.85 15.72 Bn
6 NTRA Natera, Inc. 28.09 Bn -135.14 12.18 0.02 Bn
7 MTD Mettler Toledo International Inc/ 27.29 Bn 31.39 6.78 2.15 Bn
8 DGX Quest Diagnostics Inc 22.76 Bn 23.12 2.06 5.67 Bn